Skip to content
Triangle logo TriangleGet started
← All settings

DISEASE & TREATMENT SETTING

recurrent Uterine Sarcoma

Source-derived catalogue. This is not a treatment recommendation or a personalised trial match.

Exact scope

Treatment of Recurrent Uterine Sarcoma

Broader topic: Uterine Sarcoma

Source population
Not part of this definition
Disease extent
recurrent
Treatment line
Not part of this definition
Stage
Not part of this definition
Resectability
Not part of this definition
Biomarkers, prior therapy and derivation
molecular
    prior therapy
    1. class
      prior therapy
      status
      stated
    derivation status
    source-attested
    derivation note
    Scoped from an NCI treatment-summary heading. NCI PDQ is an evidence summary, not a practice guideline, and only the dimensions the heading states are part of this definition.
    source wording
    Treatment of Recurrent Uterine Sarcoma

    Study evidence for this setting

    18 linked studies · Applicability is a draft source assessment, not a determination of your eligibility.

    NCT00025506 · Registry condition search · Scope: unclear

    Thalidomide in Treating Patients With Recurrent or Persistent Carcinosarcoma of the Uterus

    6 outcome links · 1 safety-group records · 1 quality-of-life measures

    →

    NCT00075400 · Registry condition search · Scope: unclear

    Imatinib Mesylate in Treating Patients With Recurrent or Persistent Uterine Cancer

    6 outcome links · 1 safety-group records · 0 quality-of-life measures

    →

    NCT00114218 · Registry condition search · Scope: unclear

    Gemcitabine and Docetaxel in Treating Patients With Recurrent or Persistent Uterine Cancer

    2 outcome links · 1 safety-group records · 0 quality-of-life measures

    →

    NCT00238121 · Registry condition search · Scope: unclear

    Sorafenib in Treating Patients With Advanced or Recurrent Uterine Cancer

    4 outcome links · 1 safety-group records · 0 quality-of-life measures

    →

    NCT00245102 · Registry condition search · Scope: unclear

    Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma

    1 outcome links · 6 safety-group records · 0 quality-of-life measures

    →

    NCT00390234 · Registry condition search · Scope: unclear

    Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma

    5 outcome links · 1 safety-group records · 0 quality-of-life measures

    →

    NCT00659360 · Registry condition search · Scope: unclear

    AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma

    6 outcome links · 1 safety-group records · 0 quality-of-life measures

    →

    NCT00954174 · Registry condition search · Scope: unclear

    Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer

    6 outcome links · 2 safety-group records · 4 quality-of-life measures

    →

    NCT01012297 · Registry condition search · Scope: unclear

    Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma

    4 outcome links · 2 safety-group records · 0 quality-of-life measures

    →

    NCT01061606 · Registry condition search · Scope: unclear

    Temsirolimus in Treating Patients With Recurrent or Persistent Cancer of the Uterus

    6 outcome links · 1 safety-group records · 0 quality-of-life measures

    →

    NCT01079832 · Registry condition search · Scope: unclear

    Stereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological Malignancies

    5 outcome links · 1 safety-group records · 1 quality-of-life measures

    →

    NCT01154452 · Registry condition search · Scope: unclear

    Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma

    3 outcome links · 4 safety-group records · 0 quality-of-life measures

    →

    NCT01168232 · Registry condition search · Scope: unclear

    Ixabepilone in Treating Patients With Recurrent or Persistent Uterine Cancer

    4 outcome links · 1 safety-group records · 0 quality-of-life measures

    →

    NCT01220609 · Registry condition search · Scope: unclear

    Ixabepilone in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus Previously Treated With Chemotherapy

    4 outcome links · 1 safety-group records · 0 quality-of-life measures

    →

    NCT01247571 · Registry condition search · Scope: unclear

    Pazopanib Hydrochloride in Treating Patients With Recurrent or Persistent Uterine Cancer

    5 outcome links · 1 safety-group records · 0 quality-of-life measures

    →

    NCT01553539 · Registry condition search · Scope: unclear

    Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery

    5 outcome links · 1 safety-group records · 1 quality-of-life measures

    →

    NCT01637961 · Registry condition search · Scope: unclear

    Alisertib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus

    6 outcome links · 1 safety-group records · 0 quality-of-life measures

    →

    NCT02601209 · Registry condition search · Scope: unclear

    Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma

    6 outcome links · 7 safety-group records · 0 quality-of-life measures

    →
    Source relationships and population-mapping limitations
    bindings
      mappings

        Download this complete draft source relationship record →

        Preserved source evidence · Not medical advice